Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection

PURPOSE: Bevacizumab plus fluoropyrimidine-based chemotherapy is standard treatment for first-line and second-line metastatic colorectal cancer (mCRC). However, to date, there is no current biomarker predictive for the benefit of bevacizumab use for these patients. Preclinical data suggest that the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Ghiringhelli, Francois, Bichard, Damien, Limat, Samuel, Lorgis, Veronique, Vincent, Julie, Borg, Christophe, Berthou, Julie, Orry, David, Ortega-Deballon, Pablo, Lakkis, Zaher, Facy, Olivier, Heyd, Bruno, Rat, Patrick, Nerich, Virginie, Ladoire, Sylvain
Format: Artigo
Sprog:Inglês
Udgivet: Springer US 2014
Fag:
Colorectal Cancer
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3975091/
https://ncbi.nlm.nih.gov/pubmed/24419756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3463-y
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker